The rationale is that the two agents may occupy GHRHR at slightly offset time windows, extending the total duration of pituitary stimulation within a single injection event
Having done this twice I got two very different peak levels of 33.1 and 16.3 ug/l respectively
Neither is objectively "better." The right choice depends on your goals, your body, and what you're trying to accomplish
Possible side effects include: Hypoglycemia (low blood sugar) Joint and muscle pain Headaches and nausea Injection site irritation Potential increased risk of certain cancers with prolonged high-dose use Acromegaly-like symptoms (enlarged facial features, hands, or feet) with extended high-dose usehutechlabusa.com+1catalystcliniclondon.com+1pathofpeds.com+8anabolicsza.com+8hutechlabusa.com+8catalystcliniclondon.com+9cleanfarma.ca+9pathofpeds.com+9catalystcliniclondon.com+3pathofpeds.com+3pathofpeds.com+3 Monitoring blood sugar levels and adhering to recommended dosages can mitigate some risks
Published studies utilizing IGF-1 LR3 span cell proliferation, differentiation, survival signaling, and metabolic research, reflecting the peptide's broad utility in growth factor biology